शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SUDEEPPHRMNSESudeep Pharma Limited· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 19 Dec, 2025 · 15:44 IST

Q2 FY26 results: standalone revenue dips, consolidated grows 25.6% YoY

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.9%Reaction day
₹684.00
prior close
₹662.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.4%-4.2% vs market
Specialty Chemicals peers, median of 89sector+0.4%-3.3% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.8
10m
+0.2
15m
+0.3
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.9+1.4-4.2+0.4-3.3
Next day
-5.7+1.4-7.1+0.9-6.7
2d
-8.6+0.9-9.5+0.4-9.0
3d
-9.2+0.3-9.6+0.7-9.9
4d
-9.1-0.4-8.6-0.2-8.9
5d
-11.1-0.5-10.6-0.3-10.8
1w
-12.7+1.1-13.8+0.3-13.0
15d
-10.4-2.5-7.9-2.8-7.6
1m
-20.6-6.1-14.5-6.8-13.8
2m
-7.3-2.8-4.5-6.6-0.8
3m
-13.6-14.9+1.3-19.0+5.4
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 89Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited Q2 FY26 and H1 FY26 results on 19 Dec 2025. Standalone Q2 revenue fell about 17% YoY to Rs.8,788 lakhs, PAT at Rs.2,974 lakhs. Consolidated H1 revenue grew 25.6% to Rs.28,758 lakhs, PAT up about 18.5% to Rs.7,805 lakhs. First listed results post Nov 2025 IPO at Rs.593 per share. Auditor BSR gave an unqualified limited review.

Likely market impact

Mixed first post-listing print: strong consolidated growth from subsidiaries and recent acquisition, while standalone quarter dipped. Sets baseline for tracking as a newly listed stock.